TrialPsychiatry and clinical neurosciences2020

Randomized, double-blind, 6-week non-inferiority study of lurasidone and risperidone for the treatment of schizophrenia.

Yuan Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.